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Abstract: Osteoarthritis is a degenerative articular disease with complex pathogeny because diverse factors interact caus-
ing a process of deterioration of the cartilage. Despite the multifactorial nature of this pathology, from the 50’s it´s known 
that certain forms of osteoarthritis are related to a strong genetic component. The genetic bases of this disease do not fol-
low the typical patterns of mendelian inheritance and probably they are related to alterations in multiple genes. The identi-
fication of a high number of candidate genes to confer susceptibility to the development of the osteoarthritis shows the 
complex nature of this disease. At the moment, the genetic mechanisms of this disease are not known, however, which 
seems clear is that expression levels of several genes are altered, and that the inheritance will become a substantial factor 
in future considerations of diagnosis and treatment of the osteoarthritis. 
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INTRODUCTION 
  Osteoarthritis is a degenerative articular disease with a 
complex pathogeny because diverse factors interact causing 
a process of deterioration of the cartilage and the subchon-
dral bone. It can be primary or secondary to diverse diseases, 
but it has clinical, radiological, and pathological manifesta-
tions in common. Its pathogenesis is complex due to genetic, 
metabolic and local factors, which interact and cause a proc-
ess of deterioration of the cartilage, with a proliferative reac-
tion of subchondral bone and synovial inflammation. Apart 
from the classical concept of disease being age related, os-
teoarthritis is considered as a heterogeneous group, with 
common and different aspects; its diagnosis is variable with 
real possible treatments. 
  Chondrocytes must play an important role in the early 
stages, and in the progression and development of the dis-
ease [1]. Despite this, there are various factors that have a 
relevant role in the development of the disease, such as age, 
sex, race, lifestyle, obesity, occupation or genetics [2]. Since 
the 1950s, it´s known that certain types of osteoarthritis are 
related with a strong genetic component. 
  The first study developed in this sense was carried out by 
Stechner in 1941 [3], who demonstrated that the presence of 
Heberden nodules in osteoarthritic fingers on the hand were 
three times more likely to occur in twins compared to the 
general population. It was concluded that these lesions were 
inherited as an autosomal dominant character, with an ele-
vated prevalence in women. Similar family studies per-
formed in the 1960s in the United Kingdom in individuals 
that had symptoms of general osteoarthritis showed, as in the 
previous case, that there must be a relationship between the  
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disease and being a twin sister [4]. Post studies support the 
existence of family ties in relation to suffering Heberden or 
Bouchard nodules [5-7]. 
  The genetics of this disease is complex, as it does not 
usually follow the typical pattern of mendelian inheritance 
and it is probably associated with multiple gene interactions. 
A large number of studies support the theory of a polygenic 
inheritance, as opposed to defect in a single gene [8,9]. The 
beginnings, progression and severity of the disease may be 
influenced by the development of multiple gene factors, 
which interact with diverse alterations produced by different 
genes. The genetic influence of this disease is estimated be-
tween 35% and 65% [10,11]. Epidemiological studies esti-
mate that there is a 40% probability of inheritability in an 
osteoarthritic knee and a 65% probability of inheritability in 
osteoarthritic hands and hips [12]. 
  The identification of the loci related with osteoarthritis in 
both hands and other articulations suggested that genes being 
susceptible to developing osteoarthritis are not specific to the 
articulation, which is coherent with the hypothesis “common 
variants-multiple disease”, characteristic of complex genetic 
disorders [13]. 
Identification of Candidate Genes that Confer Suscepti-
bility of Developing Osteoarthritis 
  Two approximations have traditionally been considered 
when identifying genes which confer susceptibility to devel-
oping a complex pathology: genome wide linkage scan and 
study of candidate genes. 
Genome Wide Linkage Scan 
  This procedure does not require any previous knowledge 
of the nature or function of the gene, since it is a genomic 
scan searching for genes associated in some way with the 
pathology. It is an expensive technique, which requires the Genetics in Osteoarthritis  Current Genomics, 2008, Vol. 9, No. 8    543 
genotyping of various polymorphic markers from a large 
number of affected people belonging to the same family. 
Through the development of this technique, the relationships 
between 12 chromosomes (1, 2, 4, 6, 7, 9, 11-13, 16, 19 and 
X) and this disease have been detected, showing the com-
plexity of the transmission of osteoarthritis. In distinct analy-
sis carried out on chromosomes 2p, 2q, 7p, 11q and 16p, five 
loci were detected; these chromosomes present a greater 
probability of being gene carriers involved in the os-
teoarthritic process [14-19]. 
Study of Candidate Genes 
  Study of candidate genes is orientated towards the search 
for alterations in a gene, which requires knowledge in its 
function and the possible pathological role. Some genes re-
lated with the osteoarthritic process are shown in Table 1. 
Genes that Code for Collagen  
  Among the candidate genes that play a role in the os-
teoarthritic process, the genes that code for structural pro-
teins of the extracellular matrix of the cartilage seem to have 
an important role, especially those that code for collagen 
type II (COL2A1). There are many reasons to suggest that 
alterations in this gene are responsible for the degeneration 
of the joints during the osteoarthritic process, such as the 
association of diverse mutations with distinct osteochondro-
dysplasia or the proper function of COL2A1, that codes for 
the most abundant proteins in the extracellular matrix 
Table 1.  Genes Related with the Osteoarthritic Process 
Gene  Phenotypic Manifestation   Reference 
COL11A1   Early apparition of osteoarthritis  [21, 23] 
COL11A2   Early apparition of osteoarthritis  [22] 
COL1A1   Reduction in osteoarthritis in female hips  [26] 
COL2A1   Early apparition of osteoarthritis  [20, 26, 59] 
COL9A1   Early apparition of knee osteoarthritis  [18, 27] 
COMP (cartilage oligomeric matrix protein gene)  Early apparition of hip osteoarthritis  [24, 59] 
Interleukin 1 (IL-1A, IL-1B, IL1RN)  Knee and hip osteoarthritis  [27, 38] 
Interleukin 6  Hip osteoarthritis  [40]  
Interleukin 17 (IL17A, IL17F)  Susceptibility to developing osteoarthritis  [39] 
Interleukin 4 (IL4R)  Hip osteoarthritis in females  [37] 
Oestrogen  receptor (Er)  Osteoarthritis in women  [43, 44] 
Vitamin D receptor  (VDR)  Osteoarthritis in various joints  [48, 49, 50] 
Frizzled Related Protein (FRZB)  Hip osteoarthritis in females  [51, 52, 59] 
Asporin (ASP)  Knee and hip osteoarthritis  [53, 54, 59] 
Aggrecans (AGC1)  Hand osteoarthritis  [1] 
Insulin-like growth factor 1 (IGF-1)  Increased risk in developing osteoarthritis  [1, 20, 55] 
Transforming growth factor  (TGF1) Osteoarthritis  [1] 
 Tissue inhibitor of  metaloprotease 3 (TIMP3)  Knee and hip osteoarthritis  [1] 
Metaloprotease ADAM12  Knee osteoarthritis  [58] 
Repetitions rich in leukine  Knee osteoarthritis  [17, 57] 
Calponin homology domain containing protein 1 (LRCH1)  Knee osteoarthritis  [17, 57] 
Calmodulin (CALM1)  Hip osteoarthritis in Japanese population  [59] 
Matrilin-3  Early apparition of osteoarthritis in knees and hands  [56] 
Cartilage intermediate protein (CLIP)  Knee osteoarthritis in males  [58] 
Tetranectin (TNA)  Knee osteoarthritis  [58] 
Bone morphogenic protein 2 (BMP2)  Reduction in osteoarthritis in female knees  [58] 
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[10,18,20]. Among the remaining genes that code for the 
structural proteins of the extracellular matrix, some candi-
dates present an increased susceptibility to developing the 
disease, including COL9A2, COL11A1, COL11A2 [21, 22, 
23] or COMP (cartilage oligomeric matriz protein gene) 
[24]. On the other hand, some studies suggest a protective 
role that could cause alterations in these genes. As shown in 
the study by Lian et al. (2005) [25], they concluded that 
there is an association between certain mutations in the 
COL1A1 gene and the decreased probability of suffering hip 
osteoarthritis in women. However, not all of the published 
studies support the conclusion that the candidate genes in-
crease the susceptibility to developing the disease [26,27]. 
Interleukines 
  Recent studies have demonstrated the importance of the 
inflammatory process in the pathology of osteoarthritis [28-
33]. Even though this disease is not a classic autoimmune 
process, various cytokines are involved in the metabolism of 
the cartilage and are synthesized not only by synovial cells 
but also by cartilage chondrocytes. Interleukin 1 (IL-1) is the 
main catabolic cytokine that exists in the articulation and it 
stimulates the synthesis of a number of proteinases, which 
can simultaneously destroy the extracellular cartilage. When 
the anabolic and catabolic activities of cytokines are in bal-
ance, cartilage integrity is maintained. If there is a factor that 
favours catabolism then a degenerative process within the 
cartilage will occur, resulting in a final osteoarthritic process 
[34]. Therefore, it is reasonable to suggest that various 
genes, which code for different interleukins [35], may influ-
ence genetic susceptibility to osteoarthritis. Genes coding for 
IL-1A, IL-1B, IL1RN, IL4R, IL17A, IL17F and IL6 were 
analyzed and various alterations in these regions of DNA, 
including SNPs (single nucleotide polymorphisms), micro-
satellites and VNTR (variable number tandem repeats) has 
been described and related with osteoarthritis in different 
articulations [36-40]. 
Other Genes Implicated in the Osteoarthritic Process 
  The estrogen receptor  gene (ER) is an important me-
diator in signal transduction, and is expressed in different 
cells, including human chondrocytes [41, 42]. Numerous 
alterations in this gene have shown to affect the structure and 
the function of this protein, which as a last resort can affect 
the progression of osteoarthritis [43]. Epidemiological stud-
ies carried out in women, suggest that the loss of estrogen 
may be accompanied by an increase in the prevalence of hip 
and knee osteoarthritis [44], which would help to explain the 
differences in the prevalence of this disease with respect to 
gender. 
  Vitamin D and its receptor (VDR) play an important role 
in bone metabolism, in response to the immune system, can-
cer and osteoarthritis [45]. VDR has an important function in 
regulating calcium metabolism and cellular function in bones 
[46]. Diverse studies proved the relationship between the 
levels of vitamin D in serum and the progression of os-
teoarthritis in the knee [47]. Meanwhile others reflect the 
relationship between certain polymorphisms in the gene that 
codes for vitamin D and the susceptibility of developing os-
teoarthritis in different joints [48-50]. 
  The Frizzled Related Protein gene (FRZB), which codes 
for the secretions of FRZB (FRZB3), is involved in both the 
bone formation and the negative regulation of the receptor-
signalling pathway Wnt, whose inhibition is important in 
maintaining the structure of the cartilage [51]. Different mu-
tations in this gene are related with the development of os-
teoarthritis [52]. 
  Asporins (ASP), characterized for the first time by 
Lorenzo et al. (2001) [53], are components of the extracellu-
lar matrix and expressed in high proportions in cartilage of 
osteoarthritic patients. They act as negative regulators of 
chondrogenesis, inhibiting the action of TGF by direct con-
tact [54]. 
  Apart from the genes described above, there has also 
been an increase in projects over the past few years that have 
contributed to the discovery of new genes related to os-
teoarthritis. The ones that stand out are genes that code for 
structural proteins and proteins related to the loss of carti-
lage, as well as genes related to the increase in synthesis 
of the extracellular matrix and with an adaptive response to 
the disintegration of cartilage. We can mention aggrecan 
(AGC1), insulin-like growth factor (IGF-1), transforming 
growth factor  (TGF1), tissue inhibitor of metalloprotein-
ase 3 (TIMP3), the metalloprotease gene ADAM12, leucine-
rich repeats and calponin homology domain containing 1 
gene LRCH1, the calmodulin gene (CALM1), Matrilin 3 
(MATN-3), CLIP (cartilage intermediate protein), TNA (te- 
tranectin), and BMP2 (bone morphogenic protein 2) [1,17, 
55-59].  
Cases of Non-Primary Osteoarthritis 
  Several osteoarthritis are related to alterations in HLA-
A1B8 [60], certain haplotypes of HLA-B8 [61] and with 
diverse isoforms of 1 antitrypsin [60], however not all stud-
ies show the same association [62]. In the same way differ-
ent types of rare osteoarthritis exist whose presence are re-
lated to diverse pathologies, such as the family of calcium 
pyrophosphate deposits disease (CPDD) [63,64], Stickler 
syndrome [65] and some chondrodysplasias [66], which pre-
sent a clear genetic base. 
Expression Libraries and Microarray Technology 
  In all the studies carried out up until now, sufficient evi-
dences exist to confirm that the chondrocytes play an impor-
tant role in cartilage degradation. A change in the gene ex-
pression levels of patients with this disease is expected as a 
response to both exogenous and endogenous stimuli. Based 
on this, different groups studied the genetic expression ob-
taining different responses in function to the region of carti-
lage analyzed. Kumar et al. (2001) [67] obtained the first 
cDNA library of cartilage from osteoarthritic and normal 
patients. After analyzing 10,000 EST (expressed sequence 
tags) two new homologous proteins that are well known 
were obtained [procollagen C-proteinase enhnacer protein-2 
(PCPE-2) and GalNAC transferase], and they also described 
genes which had never been described in cartilage before. 
Futher studies in this field were undertaken and in 2006 the 
number of ESTs described reached  117,000 [68] and the 
development of the transcription map in cartilage is esti-
mated to contain 16,000 genes. Genetics in Osteoarthritis  Current Genomics, 2008, Vol. 9, No. 8    545 
  Since the mid 90s the EST, clones and cDNA databases 
have contributed to important developments in microarray 
technology. At the beginning of the year 2000 investigations 
into genomic functions of the cartilage were developed, so 
Aigner et al. (2001) [69] published the first study of microar-
rays in osteoarthritis. Sato et al. (2006) [70] used Affymetrix 
GeneChip
®  technology and analyzed the gene expression 
profile of cartilage from knees of osteoarthritic patients, 
from both injured and healthy regions. They identified dif-
ferent expression levels of transcripts with respect to the 
origins of the sample. In the same study, expression levels in 
osteoarthritic and healthy individuals were compared. 
Mitochondrial Genetics in OA 
  Mitochondria are organelles present in most eukaryotic 
cells and play a crucial role in ATP synthesis by oxidative 
phosporilation (OXPHOS); furthermore, heat production, 
reactive oxygen species (ROS) generation, apoptosis and 
several metabolic pathways are some aspects in which these 
organelles are involved. Despite the glycolytic nature of ar-
ticular chondrocytes, the mitochondrially-mediated patho-
genesis of OA is being increasingly investigated [71-73]. 
Besides, given the role that the proteins encoded by the mi-
tochondrial genome play in the production of ATP, muta-
tions of mitochondrial DNA (mtDNA) are an important and 
common cause of human disease, affecting approximately 
one out every 3500 individuals [74]. 
  The evolution of human mtDNA is characterized by the 
emergence of distinct maternal lineages that defined haplo- 
groups characterized by specific mtDNA polymorphisms 
[75]. Among Europeans, 95% of the population belongs to 
one of nine haplogroups: H, I, J, K, T, U, V, W or X. Since 
mitochondrial dysfunction and defective oxidative phos-
phorylation have been linked to some human disorders
 [76], 
and given the lines of evidence that describe the contribution 
of mtDNA to cellular physiology and its critical importance 
for energy production, there are a number of studies investi-
gating the association between mtDNA haplogroups and 
multifactorial diseases [77] and aging [78]. Our group, in a 
recent study carried out in 457 knee OA subjects and 262 
radiological healthy controls from an Spanish population, 
demonstrated that European mtDNA haplogroup J is in-
volved in conferring protection from incidence (OR = 0.460; 
95% CI: 0.282 – 0.748; p = 0.002) and severity (OR = 0.351; 
95% CI: 0.156 – 0.787; p = 0.012) of knee OA, while 
mtDNA haplogroup U appears to be associated with an in-
crease in knee OA radiological grade severity (OR = 1.788; 
95% CI: 1.094 – 2.922; p = 0.025), being the first study that 
correlates mtDNA haplogroups with OA [79]. 
CONCLUSIONS 
  As described above, osteoarthritis is a complex disease 
that not only involves the cartilage; the joint and its interac-
tion with the cartilage must also be considered. Even though 
the genetic mechanisms of this disease are not actually 
known, it seems clear that expression levels in osteoarthritic 
and healthy patients are different and that genetic inheritance 
is a factor that should be considered in the near future for 
diagnosing and treating osteoarthritis. On the other hand, it is 
important to recognize the interaction between genetic and 
environmental factors (e.g. obesity, excessive stress on the 
joint articulation, or the type of occupation) as it can be criti-
cal in the clinical expression of the disease. Advances over 
the last few years in the genetic knowledge of osteoarthritis 
has allowed us to be optimistic over the early detection of 
this disease, as well as the identification of possible os-
teoarthritic subpopulations and the ability to forecast a re-
sponse when treated with different therapies. 
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